Practical considerations in the management of adults with malignant astrocytomas

Stuart A Grossman, M. Zeltzman

Research output: Contribution to journalArticle

Abstract

BACKGROUND- Malignant astrocytomas in adults are aggressive tumors that are increasing in incidence especially in the elderly. Although these appear as a localized process, intensive local therapies have failed to provide cures as a result of the invasiveness of these malignancies. Age, histology, performance status, and extent of resection are powerful prognostic factors. Unique aspects of these tumors and the brain in which they reside pose practical management dilemmas to health care providers. REVIEW SUMMARY- The complex issues regarding surgery, radiation therapy, chemotherapy, the role of research studies, and special considerations in the use of glucocorticoids, anticonvulsants, and anticoagulants in this patient population are reviewed. In addition, practical aspects of the management of patients dying of malignant astrocytomas and the importance of recognizing the unique stresses of this illness on patients and family members are discussed. Novel antineoplastic approaches, less toxic agents to control peritumoral edema, and improved supportive care are key to improving both the quality and quantity of life for patients with this devastating disease. CONCLUSION- Familiarity with the practical aspects of managing patients with malignant astrocytomas enables neurologists to provide optimal care to their patients and address the concerns of neurosurgeons, radiation therapists, oncologists, nurses, social workers, hospice personnel, and others who are increasingly involved in the care of these patients.

Original languageEnglish (US)
Pages (from-to)130-138
Number of pages9
JournalNeurologist
Volume2
Issue number2
StatePublished - 1996

Fingerprint

Astrocytoma
Hospices
Poisons
Brain Neoplasms
Health Personnel
Antineoplastic Agents
Anticonvulsants
Anticoagulants
Glucocorticoids
Edema
Neoplasms
Histology
Patient Care
Radiotherapy
Nurses
Quality of Life
Drug Therapy
Incidence
Research
Population

Keywords

  • Anticonvulsants
  • Chemotherapy
  • Glioblastoma multiforme
  • Glucocorticoids
  • Malignant astrocytoma
  • Radiation therapy
  • Supportive care
  • Surgery

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Practical considerations in the management of adults with malignant astrocytomas. / Grossman, Stuart A; Zeltzman, M.

In: Neurologist, Vol. 2, No. 2, 1996, p. 130-138.

Research output: Contribution to journalArticle

@article{b86f7bdadd5543088307ae449a62c992,
title = "Practical considerations in the management of adults with malignant astrocytomas",
abstract = "BACKGROUND- Malignant astrocytomas in adults are aggressive tumors that are increasing in incidence especially in the elderly. Although these appear as a localized process, intensive local therapies have failed to provide cures as a result of the invasiveness of these malignancies. Age, histology, performance status, and extent of resection are powerful prognostic factors. Unique aspects of these tumors and the brain in which they reside pose practical management dilemmas to health care providers. REVIEW SUMMARY- The complex issues regarding surgery, radiation therapy, chemotherapy, the role of research studies, and special considerations in the use of glucocorticoids, anticonvulsants, and anticoagulants in this patient population are reviewed. In addition, practical aspects of the management of patients dying of malignant astrocytomas and the importance of recognizing the unique stresses of this illness on patients and family members are discussed. Novel antineoplastic approaches, less toxic agents to control peritumoral edema, and improved supportive care are key to improving both the quality and quantity of life for patients with this devastating disease. CONCLUSION- Familiarity with the practical aspects of managing patients with malignant astrocytomas enables neurologists to provide optimal care to their patients and address the concerns of neurosurgeons, radiation therapists, oncologists, nurses, social workers, hospice personnel, and others who are increasingly involved in the care of these patients.",
keywords = "Anticonvulsants, Chemotherapy, Glioblastoma multiforme, Glucocorticoids, Malignant astrocytoma, Radiation therapy, Supportive care, Surgery",
author = "Grossman, {Stuart A} and M. Zeltzman",
year = "1996",
language = "English (US)",
volume = "2",
pages = "130--138",
journal = "Neurologist",
issn = "1074-7931",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Practical considerations in the management of adults with malignant astrocytomas

AU - Grossman, Stuart A

AU - Zeltzman, M.

PY - 1996

Y1 - 1996

N2 - BACKGROUND- Malignant astrocytomas in adults are aggressive tumors that are increasing in incidence especially in the elderly. Although these appear as a localized process, intensive local therapies have failed to provide cures as a result of the invasiveness of these malignancies. Age, histology, performance status, and extent of resection are powerful prognostic factors. Unique aspects of these tumors and the brain in which they reside pose practical management dilemmas to health care providers. REVIEW SUMMARY- The complex issues regarding surgery, radiation therapy, chemotherapy, the role of research studies, and special considerations in the use of glucocorticoids, anticonvulsants, and anticoagulants in this patient population are reviewed. In addition, practical aspects of the management of patients dying of malignant astrocytomas and the importance of recognizing the unique stresses of this illness on patients and family members are discussed. Novel antineoplastic approaches, less toxic agents to control peritumoral edema, and improved supportive care are key to improving both the quality and quantity of life for patients with this devastating disease. CONCLUSION- Familiarity with the practical aspects of managing patients with malignant astrocytomas enables neurologists to provide optimal care to their patients and address the concerns of neurosurgeons, radiation therapists, oncologists, nurses, social workers, hospice personnel, and others who are increasingly involved in the care of these patients.

AB - BACKGROUND- Malignant astrocytomas in adults are aggressive tumors that are increasing in incidence especially in the elderly. Although these appear as a localized process, intensive local therapies have failed to provide cures as a result of the invasiveness of these malignancies. Age, histology, performance status, and extent of resection are powerful prognostic factors. Unique aspects of these tumors and the brain in which they reside pose practical management dilemmas to health care providers. REVIEW SUMMARY- The complex issues regarding surgery, radiation therapy, chemotherapy, the role of research studies, and special considerations in the use of glucocorticoids, anticonvulsants, and anticoagulants in this patient population are reviewed. In addition, practical aspects of the management of patients dying of malignant astrocytomas and the importance of recognizing the unique stresses of this illness on patients and family members are discussed. Novel antineoplastic approaches, less toxic agents to control peritumoral edema, and improved supportive care are key to improving both the quality and quantity of life for patients with this devastating disease. CONCLUSION- Familiarity with the practical aspects of managing patients with malignant astrocytomas enables neurologists to provide optimal care to their patients and address the concerns of neurosurgeons, radiation therapists, oncologists, nurses, social workers, hospice personnel, and others who are increasingly involved in the care of these patients.

KW - Anticonvulsants

KW - Chemotherapy

KW - Glioblastoma multiforme

KW - Glucocorticoids

KW - Malignant astrocytoma

KW - Radiation therapy

KW - Supportive care

KW - Surgery

UR - http://www.scopus.com/inward/record.url?scp=0342583293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0342583293&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 130

EP - 138

JO - Neurologist

JF - Neurologist

SN - 1074-7931

IS - 2

ER -